Action Point Financial Planning’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$203 – 617
2026
Q2
$203 Buy
+1
New +$188 ﹤0.01% 2697

Other funds holding BBH

Action Point Financial Planning's BBH Position: Q3 2026 in Review

Action Point Financial Planning sold out of VanEck Biotech ETF (BBH) in Q3 2026, closing a stake of 1 share — an estimated $203 sold.

Action Point Financial Planning first reported a position in BBH in Q2 2026 and held it in 1 quarter. The position peaked at $203 in Q2 2026. 122 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

  • Action Point Financial Planning reported no remaining VanEck Biotech ETF position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 1 VanEck Biotech ETF share in Q3 2026, an estimated $203.
  • Action Point Financial Planning first reported a position in VanEck Biotech ETF in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's VanEck Biotech ETF position peaked at $203 in Q2 2026.
  • 122 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.